Cargando…

Alternative Splicing: Role in Cancer Development and Progression

Detalles Bibliográficos
Autores principales:	Sette, Claudio, Ladomery, Michael, Ghigna, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852956/ https://www.ncbi.nlm.nih.gov/pubmed/24348561 http://dx.doi.org/10.1155/2013/421606

Ejemplares similares

EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression
por: Pradella, Davide, et al.
Publicado: (2017)

Alternative Splicing: Recent Insights into Mechanisms and Functional Roles
por: Ghigna, Claudia, et al.
Publicado: (2020)

Alternative Splicing and Tumor Progression
por: Ghigna, Claudia, et al.
Publicado: (2008)

Oncogenic Alternative Splicing Switches: Role in Cancer Progression and Prospects for Therapy
por: Bonomi, Serena, et al.
Publicado: (2013)

Aberrant Alternative Splicing Is Another Hallmark of Cancer
por: Ladomery, Michael
Publicado: (2013)

Alternative Splicing Programs in Prostate Cancer
por: Sette, Claudio
Publicado: (2013)

Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets
por: Porazinski, Sean, et al.
Publicado: (2018)

Epigenetic Regulation of Alternative Splicing: How LncRNAs Tailor the Message
por: Pisignano, Giuseppina, et al.
Publicado: (2021)

Phosphorylation-Mediated Regulation of Alternative Splicing in Cancer
por: Naro, Chiara, et al.
Publicado: (2013)

Diversification of the muscle proteome through alternative splicing
por: Nakka, Kiran, et al.
Publicado: (2018)

Sam68 regulates EMT through alternative splicing–activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene
por: Valacca, Cristina, et al.
Publicado: (2010)

Targeting Splicing in Prostate Cancer
por: Antonopoulou, Effrosyni, et al.
Publicado: (2018)

Alternative Splicing and Cancer
por: Auboeuf, Didier, et al.
Publicado: (2012)

Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in Cancer
por: Siegfried, Zahava, et al.
Publicado: (2013)

Alternative splicing in endothelial cells: novel therapeutic opportunities in cancer angiogenesis
por: Di Matteo, Anna, et al.
Publicado: (2020)

Widespread Alternative Splicing Changes in Metastatic Breast Cancer Cells
por: Oh, Jagyeong, et al.
Publicado: (2021)

Global Alternative Splicing Defects in Human Breast Cancer Cells
por: Oh, Jagyeong, et al.
Publicado: (2021)

Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells
por: Bowler, Elizabeth, et al.
Publicado: (2018)

Relative strength of 5’ splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA
por: Choi, Namjeong, et al.
Publicado: (2021)

The role of alternative pre-mRNA splicing in cancer progression
por: Choi, Sunkyung, et al.
Publicado: (2023)

Regulation of BCL-X splicing reveals a role for the polypyrimidine tract binding protein (PTBP1/hnRNP I) in alternative 5′ splice site selection
por: Bielli, Pamela, et al.
Publicado: (2014)

Alternative Splicing in Human Physiology and Disease
por: Artemaki, Pinelopi I., et al.
Publicado: (2022)

The role of alternative splicing in cancer
por: Singh, Babita, et al.
Publicado: (2016)

Alternative splicing, FOXP3 and cardiovascular disease
por: Joly, Anne-Laure, et al.
Publicado: (2019)

Gene Expression Profiles Controlled by the Alternative Splicing Factor Nova2 in Endothelial Cells
por: Belloni, Elisa, et al.
Publicado: (2019)

Post-Transcriptional Regulation through Long Non-Coding RNAs (lncRNAs)
por: Pisignano, Giuseppina, et al.
Publicado: (2021)

The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x
por: Paronetto, Maria Paola, et al.
Publicado: (2007)

The alternative splicing factor Nova2 regulates vascular development and lumen formation
por: Giampietro, Costanza, et al.
Publicado: (2015)

Posttranscriptional Regulation and RNA Binding Proteins in Cancer Biology
por: Ghigna, Claudia, et al.
Publicado: (2015)

The d16HER2 Splice Variant: A Friend or Foe of HER2-Positive Cancers?
por: Castagnoli, Lorenzo, et al.
Publicado: (2019)

Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells
por: Calabretta, Sara, et al.
Publicado: (2015)

Role of alternative splicing of VEGF-A in the development of atherosclerosis
por: Zhao, Naishi, et al.
Publicado: (2018)

Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer
por: Di Matteo, Anna, et al.
Publicado: (2023)

Survival-associated alternative splicing signatures in soft tissue sarcomas
por: Ren, Xianghai, et al.
Publicado: (2020)

Therapeutic targeting of alternative splicing to inhibit hepatocellular carcinoma metastasis
por: Lee, Yun-Han
Publicado: (2022)

Alternative Splicing: From Abiotic Stress Tolerance to Evolutionary Genomics
por: Gao, Bei, et al.
Publicado: (2023)

Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression
por: Feng, Haoran, et al.
Publicado: (2020)

Combinatorial control of Spo11 alternative splicing by modulation of RNA polymerase II dynamics and splicing factor recruitment during meiosis
por: Cesari, Eleonora, et al.
Publicado: (2020)

Aerobic Exercise Induces Alternative Splicing of Neurexins in Frontal Cortex
por: Innocenzi, Elisa, et al.
Publicado: (2021)

Retraction: Role of alternative splicing of VEGF-A in the development of atherosclerosis
por: Zhao, Naishi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bfg5gje15m6rjnri4pfv6qvu8g